David Reese believes that AI’s greatest impact will come from improving the thousands of human-led decisions. If Reese, the ...

Explore how biotechnology graduates are shaping India's animal science revolution in a webinar by VIT Chennai and The Hindu.

In this podcast, Motley Fool analysts Karl Thiel, Tom King, and Tim Beyers discuss: Slow rolling chaos at the FDA and its effects on drug approvals. How to think about risk when investing in biotech.

The beauty industry has long harnessed biotechnology — namely taking the most powerful skincare ingredients in nature and recreating them using science to make them more potent, stable, ...

The Motley Fool reports that biotech stocks surged in 2025, driven by FDA approvals and a doubling of longevity investment to ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...

BioTechAnalyzer is a research and analytics platform focused on making complex FDA-related biotechnology information clear, accessible, and actionable for investors. The platform focuses on late-stage ...

Emerging from a grassroots LinkedIn group effort and with co-founder Rob Perez leaning in to grow the initiative, 2026 is shaping up to be the year of BLOC—Biopharma Leaders of Color. “The thing that ...

Suggested Citation: "7 Moving Ahead." National Academies of Sciences, Engineering, and Medicine. 2019. Forest Health and Biotechnology: Possibilities and ...

Slow rolling chaos at the FDA and its effects on drug approvals. How to think about risk when investing in biotech. A review of results from DNA researcher Twist Bioscience. Don't wait! Be sure to get ...